14.68  0.5 (3.53%)		10-21 12:44
Open: 14.17 High: 14.9912 Volume: 67,444		Pre. Close: 14.18 Low: 14.16 Market Cap: 401(M)

Short term
Mid term
Targets	6-month :	18.54	1-year :	21.66
Resists	First :	15.88	Second :	18.54
Pivot price	14.25
Supports	First :	14.29	Second :	13.31
MAs	MA(5) :	13.98	MA(20) :	14.3
	MA(100) :	13.31	MA(250) :	12.5
MACD	MACD :	-0.3	Signal :	-0.3
%K %D	K(14,3) :	41	D(3) :	24.7
RSI	RSI(14): 52.6
52-week	High :	17.22	Low :	8.5

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CARL ] has closed below upper band by 26.6%. Bollinger Bands are 28.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	14.57 - 14.63	14.63 - 14.68
Low:	13.39 - 13.45	13.45 - 13.51
Close:	14.08 - 14.18	14.18 - 14.27

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Wed, 14 Oct 2026
A newly launched system tailors spine-fusion plans and devices to patients - Stock Titan

Mon, 12 Oct 2026
Carlsmed (NASDAQ:CARL) Price Target Raised to $24.00 - MarketBeat

Mon, 12 Oct 2026
Carlsmed (NasdaqGS:CARL) Stock Forecast & Analyst Predictions - Simply Wall Street

Sat, 10 Oct 2026
Carlsmed, Inc. (NASDAQ:CARL) Stock Has Consensus Target Price of $19.25 - MarketBeat

Fri, 09 Oct 2026
CARL: Carlsmed Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Tue, 06 Oct 2026
After exercising options, Carlsmed (CARL)'s COO sells 747 shares at $14.39. - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	27 (M)
Shares Float	16 (M)
Held by Insiders	45 (%)
Held by Institutions	40.4 (%)
Shares Short	1,050 (K)
Shares Short P.Month	1,100 (K)

EPS	-1.12
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	3.08
Profit Margin	-57.5 %
Operating Margin	-58.3 %
Return on Assets (ttm)	-28.2 %
Return on Equity (ttm)	-66.2 %
Qtrly Rev. Growth	56.7 %
Gross Profit (p.s.)	1.77
Sales Per Share	2.31
EBITDA (p.s.)	-1.41
Qtrly Earnings Growth	0 %
Operating Cash Flow	-34 (M)
Levered Free Cash Flow	-26 (M)

PE Ratio	-13.25
PEG Ratio	0
Price to Book value	4.75
Price to Sales	6.34
Price to Cash Flow	-11.76

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.